LinkedIn Image Treatment‐Free Remission in CML: Is It Time to Take the Leap?

Treatment‐Free Remission in CML: Is It Time to Take the Leap?

View Activity

Activity Features

Downloadable Slides

Interactive Presentation

Activity Overview

Enhance your understanding of treatment-free remission (TFR) in CML with this webcast of our symposium held during the 19th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy in Estoril. An overview of current chronic myeloid leukemia (CML) treatment approaches in terms of successes and challenges are covered, including criteria to attempt TFR and the appropriate patient selection for and management of patients in TFR.

Topics

Contemporary treatment of CML: Successes and challenges
Giuseppe Saglio, MD

The rationale and evidence for a TFR approach
Timothy Hughes, MD, FRACP, FRCPA, FAAHMS

From concept to practice: Practical implications and applications of TFR
Delphine Rea, MD, PhD

Decision-Making for TFR Candidates: Practical Examples
Faculty panel discussion

prIME Points™
Timothy Hughes, MD, FRACP, FRCPA, FAAHMS

Faculty

  • Timothy Hughes, MD, FRACP, FRCPA, FAAHMSUniversity of Adelaide
    Adelaide, Australia
  • Delphine Rea, MD, PhDHôpital Saint-Louis
    Paris, France
  • Giuseppe Saglio, MDUniversity of Turin
    Turin, Italy

Target Audience

This educational activity is specifically designed to meet the needs of hematologists and other healthcare professionals involved in the treatment of patients with CML.

The information in this activity is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before participating in the activity. This activity may contain information on products outside the approved indications where you practice.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe clinical outcomes associated with current CML treatment approaches in terms of successes and challenges
  • Identify criteria for attempting TFR based on currently available evidence and discuss optimal treatment approaches for achieving these criteria
  • Discuss appropriate patient selection for TFR and management of patients in TFR

Independent Medical Education (IME)

This IME activity is organized by prIME Oncology. This activity provides content that is evidence-based, balanced, and free of commercial bias, with a primary objective to improve competence and performance of learners in order to improve patient care.

Logo_IME_120

View Activity

The information in this activity is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before participating in the activity. This activity may contain information on products outside the approved indications where you practice.

Provider

This enduring activity is provided by prIME Oncology.

Support

This educational activity is supported by a grant from Novartis Oncology.

Activity Date

RELEASE DATE
November 7, 2017

EXPIRATION DATE
November 7, 2018